BD Marks Milestone with First Phasix™ Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced a significant ...
MassDevice

BD reports Phasix hernia mesh clinical trial milestone

BD (NYSE: BDX) today announced the first Phasix hernia mesh laparotomy reinforcement case performed in Greece.
Becker's ASC

More data back use of prophylactic mesh for laparotomy closure — 5 takeaways

Despite the dramatic drop in hernia rates and costs, U.S. surgeons are still resistant to the idea. Here are five takeaways: 1. Sherry Wren, MD, professor surgery at the Stanford University School of ...